 Currently, I'm coordinating a study whose aim is to investigate the immunological markers that are associated with protection against COVID-19 in Malawi adults. We know that about 80% of the individuals that will be exposed to the SARS-CoV-2 virus will either remain asymptomatic or develop a marked form of the disease. What we want to find out is whether just exposure to the SARS-CoV-2 virus induces an immune response that is significant to prevent these infiduos for reinfection in the future. COVID-19 has changed the lifestyle of many Malawians. We've seen a lot of people working from home, but also people changing the way they conduct social gatherings, such as weddings. This work is of particular importance in non-mino-income settings like Malawi, where it has been hard to enforce some of the preventative measures. We hope that the knowledge gained from this study will contribute to the easing of public health measures, such as social distancing. But we also want to validate serological-based tests for SARS-CoV-2. I would define success against COVID-19 as a point where we have controlled the global cases and mortality, but also the development of a vaccine that is able to protect individuals from COVID-19.